Learn more about PROMACTA® (eltrombopag) and its uses in treating severe aplastic anemia (SAA), including safety information and immunosuppressive therapy.
Ponatinib is a medication that is used to treat chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) when other treatments have not been effective. Like all medications, Ponatinib has potential side effects. Here are some of the most common ones: